Jessica Chubak, PhD

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Senior Investigator, Kaiser Permanente Washington Health Research Institute

Jessica.Chubak@kp.org
206-287-2556
Animal-assisted interactions research on Facebook

Curriculum vitae (CV)

Biography

Jessica Chubak, PhD, is an epidemiologist who works to improve cancer diagnosis, treatment, control, and survivorship. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Intrigued by how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data in epidemiologic and health services studies.

Dr. Chubak joined KPWHRI in 2007, bringing expertise in epidemiologic methods, pharmacoepidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand before completing her PhD in Epidemiology at the University of Washington (UW). Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the UW School of Public Health, where she enjoys guest-lecturing and getting to work with students.

Research interests and experience

Cancer

Epidemiology; colorectal cancer; medication use; survivorship; recurrence; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship
Health Services & Economics

Screening
Medication Use & Patient Safety

Cancer risk and use of common medications

Recent publications

Kamineni A, Doria-Rose VP, Chubak J, Inadomi JM, Corley DA, Haas JS, Kobrin SC, Winer RL, Lafata JE, Beaber EF, Yudkin JS, Zheng Y, Skinner CS, Schottinger JE, Ritzwoller DP, Croswell JM, Burnett-Hartman AN. Evaluation of harms reporting in U.S. cancer screening guidelines. Ann Intern Med. 2022 Sep 27. doi: 10.7326/M22-1139. Online ahead of print. PubMed

Chubak J, Dalmat RR, Weiss NS, Doria-Rose VP, Corley DA, Kamineni A. Informative presence in electronic health record data: a challenge in implementing study exclusion criteria. Epidemiology. 2023 Jan 1;34(1):29-32. doi: 10.1097/EDE.0000000000001542. Epub 2022 Sep 20. PubMed

Chao CR, Chubak J, Beaber EF, Kamineni A, Mao C, Silverberg MJ, Tiro JA, Skinner C, Garcia M, Corley DA, Winer RL, Raine-Bennett T, Feldman S, Wheeler CM. Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2022 Sep 15. doi: 10.1002/cam4.5226. Online ahead of print. PubMed

Dalmat RR, Ziebell RA, Kamineni A, Phipps AI, Weiss NS, Breslau ES, Corley DA, Green BB, Halm EA, Levin TR, Schottinger JE, Chubak J. Risk of colorectal cancer and colorectal cancer mortality beginning ten years after a negative colonoscopy, among screen-eligible adults 76-85 years old. Cancer Epidemiol Biomarkers Prev. 2022 Sep 13:EPI-22-0581. doi: 10.1158/1055-9965.EPI-22-0581. [Epub ahead of print]. PubMed

Chubak J, Burnett-Hartman AN, Barlow WE, Corley DA, Croswell JM, Neslund-Dudas C, Vachani A, Silver MI, Tiro JA, Kamineni A. Estimating cancer screening sensitivity and specificity using healthcare utilization data: defining the accuracy assessment interval. Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1517-1520. doi: 10.1158/1055-9965.EPI-22-0232. PubMed

Beaber EF, Kamineni A, Burnett-Hartman AN, Hixon B, Kobrin SC, Li CI, Oliver M, Rendle KA, Skinner CS, Todd K, Zheng Y, Ziebell RA, Breslau ES, Chubak J, Corley DA, Greenlee RT, Haas JS, Halm EA, Honda S, Neslund-Dudas C, Ritzwoller DP, Schottinger JE, Tiro JA, Vachani A, Doria-Rose VP. Evaluating and improving cancer screening process quality in a multilevel context: the PROSPR II consortium design and research agenda. Cancer Epidemiol Biomarkers Prev. 2022 Aug 2;31(8):1521-1531. doi: 10.1158/1055-9965.EPI-22-0100. PubMed

Nicholson BD, Thompson MJ, Hobbs FDR, Nguyen M, McLellan J, Green B, Chubak J, Oke JL. Measured weight loss as a precursor to cancer diagnosis: retrospective cohort analysis of 43Â 302 primary care patients. J Cachexia Sarcopenia Muscle. 2022 Oct; 13(5): 2492-2503. Published online 2022 Jul 28. doi: 10.1002/jcsm.1305. PubMed